NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neovision Capital

Neovision Capital

Shanghai, Shanghaineovisioncap.com

Overview

Neovision Capital is an investment fund that specializes in the venture capital investments in growth companies. The firm prefers to invest in the healthcare, information technology, TMT and consumer products and services sectors. The company leverages its team's extensive operational experience in China, along with international resources, to provide strategic support to its portfolio companies. This includes expertise in areas such as branding, marketing, channel development, overseas expansion, human resources, and finance. Neovision Capital also maintains a presence in Nanjing.

Year Founded

2015

Portfolio Companies

13

Investments

Neovision Capital investments
CompanyDateStageLead
BrioHealth SolutionsJul 2025Series ELead
BrioHealth SolutionsJul 2025Series ELead
Sino-Biocan (Shanghai) Biotech LtdMar 2024Series BCo-investor
Qingdao Single-Cell Biotechnology Co., Ltd.Jul 2022Pre SeedLead
ALVA SystemsDec 2021Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.